Rue (Ruta graveolens)

Rue (Ruta graveolens) is a Mediterranean herb containing rutin and furoquinoline alkaloids that demonstrate anti-cancer and neuroprotective properties. These compounds work through selective cytotoxic effects on cancer cells and reduction of neuroinflammatory markers.

Origin & History

Rue (Ruta graveolens) is a perennial herb from the Rutaceae family, native to the Mediterranean region and cultivated globally for medicinal use. The aerial parts (leaves and stems) are extracted using methanolic, water, or hydroalcoholic methods to obtain bioactive compounds including quinoline alkaloids, flavonoids, and volatile oils.

Historical & Cultural Context

Rue has been used for centuries in Traditional Chinese Medicine for fever, toothache, headache, bruises, and sprains. European and Mediterranean herbalism has employed it since ancient Greek and Roman times for inflammation and spasms, with continuous use in folk medicine traditions.

Health Benefits

• May support quality of life in advanced cancer patients (preliminary human evidence from one pilot study, n=31) • Shows selective anti-cancer activity against glioblastoma and other cancer cells (preclinical evidence only) • Demonstrates neuroprotective effects through reduction of inflammatory markers post-ischemia (animal studies only) • Exhibits anti-fibrotic properties in liver tissue via TGF-β downregulation (preclinical evidence) • Contains rutin which shows MAO-B inhibition for potential neuroprotection (in vitro studies)

How It Works

Rue's bioactive compounds, particularly rutin and furoquinoline alkaloids like rutacridone, exhibit selective cytotoxicity against cancer cells through apoptosis induction and cell cycle arrest. The herb's neuroprotective effects occur via inhibition of pro-inflammatory cytokines and reduction of oxidative stress markers in neural tissue. Rutin specifically modulates NF-κB signaling pathways to reduce inflammatory responses.

Scientific Research

Human clinical evidence is extremely limited, with only one open-label pilot study (PMID: 25439039) of 31 advanced cancer patients using homeopathic Ruta graveolens 9c, showing transitory improvements in quality of life scores at 8 and 16 weeks. No randomized controlled trials or meta-analyses exist; all other evidence comes from preclinical in vitro and animal studies.

Clinical Summary

Human evidence for rue is extremely limited, with only one pilot study (n=31) showing improved quality of life in advanced cancer patients. Preclinical studies demonstrate selective anti-cancer activity against glioblastoma cells with IC50 values around 25-50 μg/mL. Laboratory research shows neuroprotective effects through 40-60% reduction in inflammatory markers, but no human trials have confirmed these benefits. The evidence remains preliminary and insufficient for therapeutic recommendations.

Nutritional Profile

Rue (Ruta graveolens) is primarily used as a medicinal herb rather than a dietary staple, so macronutrient content is negligible in typical usage doses. Key bioactive compounds include: Alkaloids — arborinine, graveoline, graveolinine, and kokusaginine (total alkaloid content approximately 0.1–0.5% dry weight); Flavonoids — rutin (quercetin-3-rutinoside) is the dominant flavonoid at approximately 1–2% dry weight, alongside quercetin and kaempferol glycosides; Furanocoumarins — psoralen, bergapten, xanthotoxin, and isopimpinellin (collectively 0.1–0.3% dry weight), which are photosensitizing compounds with notable bioactivity; Volatile essential oils — 2-undecanone and 2-nonanone are primary constituents (comprising up to 40–90% of essential oil fraction depending on chemotype); Quinoline alkaloids — dictamnine and skimmianine present in small quantities (~0.05% dry weight); Acridone alkaloids — rutacridone present in trace amounts. Rutin bioavailability is moderate in humans (~20–30% absorption), enhanced by gut microbial hydrolysis to quercetin aglycone. Furanocoumarins are well-absorbed orally but undergo significant first-pass metabolism. The herb contains minimal protein (<2% dry weight), negligible fat, and low fiber relative to culinary herbs. Vitamin C has been reported in fresh leaf tissue (~25 mg/100g fresh weight) and small amounts of provitamin A carotenoids are present. Calcium and iron are present at low concentrations (~200 mg and ~3 mg per 100g dry weight respectively), though bioavailability is limited by the herb's typical micro-dose consumption and presence of antinutritional furanocoumarin complexes.

Preparation & Dosage

No clinically studied dosages for crude Ruta graveolens extracts exist in humans. The only human study used homeopathic Ruta graveolens 9c at two 1-mL ampoules daily. Preclinical studies used 16 mg/mL methanolic extracts in vitro or 10 mg/kg rutin-equivalent water extracts in animals, with no established human translation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rutin, Quercetin, Green Tea Extract, Turmeric, Milk Thistle

Safety & Interactions

Rue is potentially toxic and can cause severe skin photosensitivity, gastrointestinal upset, and liver damage at higher doses. The herb is contraindicated during pregnancy due to abortifacient properties and uterine stimulation effects. Rue may interact with anticoagulant medications due to its coumarin content and can potentiate photosensitizing drugs. Safe dosage limits have not been established in humans, making supplementation risky without medical supervision.